Locate family members with the last name MASIHIPOUR.

Behnam Masihipour is an academic who published a paper in 2022 entitled The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial. The paper was published in a journal entitled Evidence-based Complementary and Alternative Medicine : eCAM.

is current Senior Business Development Manager of Clifford Hallam Healthcare with Key Responsibilities • Grow, expand and build on CH2 customer base in Victoria within the retail pharmacy and hospital sectors. • Develop and implement territory specific sales plans, with both short and long-term goals. • Manage current and existing accounts and facilitating their growth with CH2 • Create and explore new business opportunities for CH2 within the pharmacy and hospital sectors. • Liaise with other departments within CH2 to ensure excellent service which meets customer satisfaction. • Constant communication with team members. • Development of strategic techniques needed to handle rejection and objection of pharmacies. • Delivering superior sales techniques by fully planning each call with specific objectives tailored to specific pharmacies/hospitals and their needs.
 ©

Niloufar Masihipour is an academic who published a paper in 2023-04-14 entitled Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. The paper was published in a journal entitled Frontiers in Oncology.